Introduction
Molecular aberrations involving the mixed lineage leukemia (MLL) gene on 11q23 are found in 5-10% of acute leukemia cases 1 . In B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) these aberrations are largely restricted to the immature CD10-negative immunophenotypes (pro-B and CD10-negative pre-B). The translocation t(4;11)(q22;q23) with MLL-AF4 (MLL-AFF1) fusion is known to be the most prevalent MLL fusion gene in ALL but precise and reliable data regarding the prevalence of the different MLL fusion partner genes, i.e. the MLL "recombinome" in adult ALL are lacking. Knowledge of the MLL recombinome is warranted since MLL fusions are of interest in detecting minimal residual disease in affected patients 2, 3 and also because controversy exists over whether adult ALL patients with pro-B ALL immunophenotype with or without MLL aberration might have a different prognosis [4] [5] [6] . We report our experience within the framework of the German Multicenter Therapy 
Nucleic acid isolation and reverse transcription
Total RNA was isolated using the TRIzol method (Gibco BRL/Invitrogen, Carlsbad, CA, USA) or the RNEasy kit (QIAGEN, Hilden, Germany). Genomic DNA was isolated using the PureGene Kit (Gentra Systems, Minneapolis, MN, USA). Reverse transcription was done using the Ready-To-Go Beads (Amersham Biosciences, Piscataway, NJ, USA) following the protocol as recommended by the supplier.
PCR for BCR-ABL, MLL-AF4, MLL-ENL, MLL-AF9
All cDNA samples were investigated for BCR-ABL by two different PCR methods as described recently 8 . These two PCR methods each included an internal control reaction as a control for RNA integrity. In addition, all samples obtained before 2006
were investigated for MLL-AF4 by a nested PCR, as described elsewhere 9 TCTGGGCTTGGGGAAGCTGTC, and CTCCTCGCCTGACGAAGAGT.
In summary, each patient sample was investigated by 7 different PCRs. 
PCR methods for other

Immunophenotypic analysis
Immunophenotypic analysis was performed as outlined in detail previously 9 using a 
Long-distance inverse (LDI-) PCR
LDI-PCR was performed at the DCAL (Frankfurt) as described previously 13 . Briefly, 1µg of genomic DNA was digested with restriction enzymes and re-ligated to form DNA circles before LDI-PCR using MLL-specific primers. Restriction polymorphic PCR amplimers were isolated from the gel and subjected to DNA sequence analyses to obtain the patient-specific fusion sequences.
DNA sequencing
DNA sequencing was performed mainly at the DCAL (Frankfurt) using standard methods on an ABI sequencer. Selected cases and MLL fusion mRNA transcripts
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Results
Overall, sufficient material from 184 BCR-ABL-negative patients with a CD10-negative BCP immunophenotype was obtained at the central diagnostic laboratory of the GMALL study group that allowed a detailed genetic analysis (Figure 1a Patients with a breakpoint in bcr2 showed a tendency towards female preponderance and older age at diagnosis, but this finding was not statistically significant. Also, the immunophenotype and WBC did not differ significantly between patients with breakpoints in bcr1 and bcr2.
The second most prevalent fusion gene was MLL-ENL in 11 cases (6,0%; 9 cyIg-, 2 cyIg+). ENL exon 2 was fused at the cDNA level to MLL exon 9 (2 patients), 10 (2 patients), 11 (6 patients) or 12 (1 patient). However, at the genomic level, 3 breakpoints (EMBL: AM050805, AM949727, AM050803) were found around 30 kB, 25 kB and 25 kb 3' of the first ENL exon indicating a spliced fusion mechanism in these cases 14 . The remaining 8 breakpoints were located in ENL intron 1.
In two patients, a 57-year-old and a 67-year-old female, LDI-PCR analysis revealed a Eleven patients (6.0%) showed an MLL-ENL fusion which is roughly the same prevalence as previously reported in children using cytogenetics 16 . For adult ALL only very few data concerning prevalence and prognostic impact of MLL-ENL are available. All patients revealed a fusion of ENL exon 2 to MLL exons at the RNA level. Three spliced fusions 14 with chromosomal breakpoints far 3' upstream of ENL were detected by LDI-PCR.
MLL-TET1 fusion with chromosomal breakpoints in
Two patients had an MLL-TET1 fusion. TET1 (CXXC6) was first identified as fusion partner of MLL in an AML case with trilineage dysplasia and t(10;11)(q22;q23) 17 .
Two other AML cases with MLL-TET1 were described by Lohrsbach et al. . ACTN4 appears to be expressed nearly ubiquitously 21 and this is in line with the finding in our patient that not only the MLL-ACTN4 but also the reciprocal ACTN4-MLL fusion transcript could be detected.
ACTN4 has not been associated with malignant diseases yet.
One patient showed a partial internal duplication of the MLL gene (MLL-PTD) with duplication of exons 3-10 at the mRNA level. MLL-PTD is a fairly common aberration in AML and detected in 5-8% of cases 22 
